163 related articles for article (PubMed ID: 22460077)
1. Posttranslational modification of indoleamine 2,3-dioxygenase.
Fujigaki H; Seishima M; Saito K
Anal Bioanal Chem; 2012 Jun; 403(7):1777-82. PubMed ID: 22460077
[TBL] [Abstract][Full Text] [Related]
2. Strategy for comprehensive identification of post-translational modifications in cellular proteins, including low abundant modifications: application to glyceraldehyde-3-phosphate dehydrogenase.
Seo J; Jeong J; Kim YM; Hwang N; Paek E; Lee KJ
J Proteome Res; 2008 Feb; 7(2):587-602. PubMed ID: 18183946
[TBL] [Abstract][Full Text] [Related]
3. Identification of Human IDO1 Enzyme Activity by Using Genetically Encoded Nitrotyrosine.
Zheng Z; Guo X; Yu M; Wang X; Lu H; Li F; Wang J
Chembiochem; 2020 Jun; 21(11):1593-1596. PubMed ID: 31944493
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantification of protein posttranslational modifications.
Farley AR; Link AJ
Methods Enzymol; 2009; 463():725-63. PubMed ID: 19892200
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characteristics and inhibitor selectivity of mouse indoleamine 2,3-dioxygenase-2.
Austin CJ; Mailu BM; Maghzal GJ; Sanchez-Perez A; Rahlfs S; Zocher K; Yuasa HJ; Arthur JW; Becker K; Stocker R; Hunt NH; Ball HJ
Amino Acids; 2010 Jul; 39(2):565-78. PubMed ID: 20140689
[TBL] [Abstract][Full Text] [Related]
6. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
Mazarei G; Budac DP; Lu G; Lee H; Möller T; Leavitt BR
Exp Neurol; 2013 Nov; 249():144-8. PubMed ID: 23994717
[TBL] [Abstract][Full Text] [Related]
7. Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.
Yuasa HJ; Mizuno K; Ball HJ
FEBS J; 2015 Jul; 282(14):2735-45. PubMed ID: 25950090
[TBL] [Abstract][Full Text] [Related]
8. Post-translational modifications of Desulfovibrio vulgaris Hildenborough sulfate reduction pathway proteins.
Gaucher SP; Redding AM; Mukhopadhyay A; Keasling JD; Singh AK
J Proteome Res; 2008 Jun; 7(6):2320-31. PubMed ID: 18416566
[TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
Thomas SN; Yang AJ
Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
[TBL] [Abstract][Full Text] [Related]
10. Molecules in focus: indoleamine 2,3-dioxygenase.
King NJ; Thomas SR
Int J Biochem Cell Biol; 2007; 39(12):2167-72. PubMed ID: 17320464
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of indoleamine 2,3-dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice.
Takamatsu M; Hirata A; Ohtaki H; Hoshi M; Ando T; Ito H; Hatano Y; Tomita H; Kuno T; Saito K; Seishima M; Hara A
Cancer Sci; 2015 Aug; 106(8):1008-15. PubMed ID: 26033215
[TBL] [Abstract][Full Text] [Related]
12. Global profiling of histone modifications in the polyomavirus BK virion minichromosome.
Fang CY; Shen CH; Wang M; Chen PL; Chan MW; Hsu PH; Chang D
Virology; 2015 Sep; 483():1-12. PubMed ID: 25958155
[TBL] [Abstract][Full Text] [Related]
13. Systematic screening of protein modifications in four kinases using affinity enrichment and mass spectrometry analysis with unrestrictive sequence alignment.
Zhang K; Zhu Y; He X; Zhang Y
Anal Chim Acta; 2011 Apr; 691(1-2):62-7. PubMed ID: 21458632
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evolution of vertebrate indoleamine 2, 3-dioxygenases IDOs from monotremes and marsupials.
Yuasa HJ; Ball HJ; Ho YF; Austin CJ; Whittington CM; Belov K; Maghzal GJ; Jermiin LS; Hunt NH
Comp Biochem Physiol B Biochem Mol Biol; 2009 Jun; 153(2):137-44. PubMed ID: 19402226
[TBL] [Abstract][Full Text] [Related]
15. Software eyes for protein post-translational modifications.
Na S; Paek E
Mass Spectrom Rev; 2015; 34(2):133-47. PubMed ID: 24889695
[TBL] [Abstract][Full Text] [Related]
16. Emerging mass spectrometry-based technologies for analyses of chromatin changes: analysis of histones and histone modifications.
Shah B; Kozlowski RL; Han J; Borchers CH
Methods Mol Biol; 2011; 773():259-303. PubMed ID: 21898261
[TBL] [Abstract][Full Text] [Related]
17. Optimization of apolipoprotein-B-100 sequence coverage by liquid chromatography-tandem mass spectrometry for the future study of its posttranslational modifications.
Delporte C; Van Antwerpen P; Zouaoui Boudjeltia K; Noyon C; Abts F; Métral F; Vanhamme L; Reyé F; Rousseau A; Vanhaeverbeek M; Ducobu J; Nève J
Anal Biochem; 2011 Apr; 411(1):129-38. PubMed ID: 21129357
[TBL] [Abstract][Full Text] [Related]
18. Uncommon posttranslational modifications in proteomics: ADP-ribosylation, tyrosine nitration, and tyrosine sulfation.
Bashyal A; Brodbelt JS
Mass Spectrom Rev; 2024; 43(2):289-326. PubMed ID: 36165040
[TBL] [Abstract][Full Text] [Related]
19. Research progress of indoleamine 2,3-dioxygenase inhibitors.
Jiang T; Sun Y; Yin Z; Feng S; Sun L; Li Z
Future Med Chem; 2015; 7(2):185-201. PubMed ID: 25686005
[TBL] [Abstract][Full Text] [Related]
20. Study of Phanerochaete chrysosporium secretome revealed protein glycosylation as a substrate-dependent post-translational modification.
Adav SS; Ravindran A; Sze SK
J Proteome Res; 2014 Oct; 13(10):4272-80. PubMed ID: 25162795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
